The Latest in Critical Care, 10/23/23 (Issue #17)
PulmCCM
OCTOBER 23, 2023
Cefepime crosses the blood-brain barrier, and dozens of case reports have associated the drug with seizures, encephalopathy, delirium, and coma, with a possibly increased incidence of neurologic adverse effects among patients with renal failure or sepsis.
98 
Let's personalize your content